packagePanitumumab

panitumumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Panitumumab is a monoclonal antibody that blocks EGFR and is used to treat colorectal cancers, including colon and rectal cancer. It is authorised in the European Union for colorectal cancer and is an approved drug, though it also remains under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q417775 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:panitumumab
ATC codes:L01FE02, L01XC08
DrugBank:DB01269
Wikidata:Q417775

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown